Friday, April 3, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
  • Surveys

    Surveys

    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026
    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
  • Surveys

    Surveys

    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026
    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

Administrative Acts of Healthcare Crime

The FDA is using the DOJ to turn regulations into crimes

Daily Remedy by Daily Remedy
March 28, 2024
in Politics & Law
0
Administrative Acts of Healthcare Crime

Public perception is a funny thing. It’s an illusion we all see, know full well it’s an illusion, and we accept it. Through public perception, lies become truths and opinions become law.

“I’m fully aware of the misperceptions that are out there and aren’t consistent with the known science. We do know that e-cigarettes — as a general class — have markedly less risk than a combustible cigarette product. That said, I think it’s very critical that we inform any communication campaigns using science and evidence. It has to be very carefully thought out to ensure that we’re maximizing impact and avoiding unintended consequences.”

Those were the words of Dr. Brian King, Director of the Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP), conveyed in a recent interview when asked about the balance between traditional cigarettes – the combustible cigarette product – and electronic cigarettes, better known as vaping cigarettes.

He was nuanced and insightful in the interview, keen to parse through the clinical evidence and the compromises needed to enact public health policy. Yet, his words stand in contrast with the administrative actions of the FDA, which recently requested the Department of Justice (DOJ) to file injunctions – a court order requiring an entity to cease a specific action – against six vaping cigarette manufacturers. The injunctions demand the six companies immediately cease the production and sale of their electronic cigarettes.

It was a blunt and direct action, one that contradicts Dr. King’s earlier words. Whereas before he was keen to stick to clinical data, now it appears he’s willing to be quite heavy-handed.

“We will not stand by as manufacturers repeatedly break the law, especially after being afforded multiple opportunities to comply.”

This was Dr. King in an excerpt cited from the official notice provided by the FDA detailing the injunctions unveiled in coordination with the DOJ. He was referencing the many warning letters issued by the FDA to the six companies. Indeed, the FDA had made multiple attempts in good faith, requesting the companies to comply with their standards.

Between January 2021 and September 2022, the FDA issued nearly 300 warning letters. Despite the sufficient notice, the companies failed to comply. As a result, for the first time, the FDA initiated injunction proceedings to enforce their regulations.

In all fairness, these six manufacturers left the FDA with no choice. They were all warned, educated on the regulatory requirements, but failed to comply.

When viewed in isolation, it seems like the appropriate course of action by the FDA. In the world of public perception, however, it feels like something different. It feels like the government is encroaching into the vaping cigarette industry.

When phrased in such an explicit way, it sounds preposterous. The FDA was simply enforcing regulatory rules that all tobacco companies must comply with. What’s the harm in that?

Well, the harm comes from the unintended consequences, which manifest through the public perceptions gleaned by the media coverage. This injunction, when coupled with other acts of federal oversight, namely the string of lawsuits against lead vaping manufacturer Juul, and the growing number of crackdowns against illicit vaping manufacturers, feels like another nail in the coffin for vaping.

Most of the internet feels the same way. Since the injunction was announced, the number of Google searches for “vaping” and “banned” has increased significantly. Even the framing of vaping on the internet has shifted. We see article after article highlighting the same refrain that begins by claiming how we all erroneously believed vaping was a safer alternative, and ends by referencing studies that highlight the side effects of vaping while coupling it with adolescent drug use, as though it’s the preferred drug of abuse among teens.

This is yet another instance of good reporting leading to unintended misinformation. Journalists use data to tell stories. As it currently stands, the data show teens are suffering from lung injuries because of vaping abuse.

While vaping is undoubtedly abused, it’s also helpful when used in the right context. That’s the problem. Data is often manipulated to tell only a part of the story. The context gives data clinical relevance.

The average age of those who indulge in vaping cigarettes is comparable to those who use traditional cigarettes and most usually begin after switching from traditional cigarettes. Clinical studies authorized by the National Institutes of Health (NIH) verify that vaping is safer than traditional cigarettes, when the two are evaluated side by side, as one alternative versus the other. The heightened risk of vaping comes mostly when it’s combined with traditional cigarettes, as the two lead to different forms of lung injury. The context of use determines the overall risk to the user.

But the framing has been set, and now the die is cast. The narrative that vaping is more dangerous than traditional cigarettes and that it’s a drug of abuse among adolescents has been firmly cemented into the American zeitgeist. And no data, no matter how well conveyed, can undo the damage caused by public perception.

The greatest irony of all is that the person who is most aware of the damage caused by the unintended consequences of false narratives is also the one creating those perceptions.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Comments 0

  1. Jim McDonald says:
    3 years ago

    This is a reasonable article. However, no one has ever used the term “vaping cigarettes.” They are electronic cigarettes, better known as e-cigarettes — or just vapes.

    Reply
    • Jay K Joshi says:
      3 years ago

      Thank you for the clarification.

      Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

Most employers are unknowingly steering their health plans toward higher costs and reduced control — until they understand how fiduciary missteps and anti-competitive contracts bleed their budgets dry. Katie Talento, a recognized health policy leader, reveals how shifting the network paradigm can save millions by emphasizing independent providers, direct contracting, and innovative tiering models.

Grounded in real-world case studies like Harris Rosen’s community-driven initiative, this episode dives deep into practical strategies to realign incentives—focusing on primary care, specialty care, and transparent vendor relationships. You'll discover how traditional carrier networks are often Trojan horses, locking employers into costly, opaque arrangements that undermine fiduciary duties. Katie breaks down simple yet powerful reforms: owning your data, eliminating conflicts of interest, and outlawing anti-competitive contract clauses.

We explore how a post-network framework—where patients are free to choose providers without restrictive network barriers—can massively reduce costs and improve health outcomes. You'll learn why independent, locally owned providers are vital to rebuilding trust, reducing unnecessary procedures, and reinvesting savings into the community. This conversation offers clarity on the unseen legal landmines employers face and actionable ways to craft health plans built on transparency, independence, and aligned incentives.

Perfect for HR pros, benefits advisors, physicians, and employer leaders committed to transforming healthcare from the ground up. If you’re tired of broken healthcare models draining your budget and frustrating your staff, this episode will empower you to take control by understanding and reshaping the very foundations of employer-sponsored health. Discover the blueprint for smarter, fairer, and more sustainable benefits.

Visit katytalento.com or allbetter.health to connect directly and explore how these innovations can work for your organization. Your path toward a healthier, more cost-effective future starts here.

Chapters

00:00 Introduction to Employer-Sponsored Health Plans
02:50 Understanding ERISA and Fiduciary Responsibilities
06:08 The Misalignment of Clinical and Financial Interests
08:54 Enforcement and Legal Implications for Employers
11:49 Redefining Networks: The Post-Network Framework
25:34 Navigating Healthcare Contracts and Cash Payments
27:31 Understanding Employer Health Plan Structures
28:04 The Role of Benefits Advisors in Health Plans
30:45 Governance and Data Ownership in Health Plans
37:05 Case Study: The Rosen Hotels' Health Model
41:33 Incentivizing Healthy Choices in Healthcare
47:22 Empowering Primary Care and Independent Providers
The Hidden Costs Employers Don’t See in Traditional Health Plans
YouTube Video xhks7YbmBoY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

by Daily Remedy
March 30, 2026
0

Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Neuralink's Healthcare Ambitions

    Neuralink’s Healthcare Ambitions

    1 shares
    Share 0 Tweet 0
  • When the Family Doctor Can’t Communicate

    1 shares
    Share 0 Tweet 0
  • A Two Headed Monster – State Attorneys General and the Drug Enforcement Agency

    3 shares
    Share 0 Tweet 0
  • What’s Next for the Obesity Industrial Complex

    0 shares
    Share 0 Tweet 0
  • Financial Toxicity

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy